Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-09-09
1994-08-23
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 530324, 530325, A61K 3700, C07K 500
Patent
active
053408004
ABSTRACT:
Peptide medicaments, and antibody thereto, useful for treating or preventing diseases, particularly diseases involving an inflammatory response by a host organism against infection, that are preferably derived from the .beta. subunit, CD18, of the leukocyte integrins, and that have the property of either interfering with, or preventing undesirable leukocyte adhesion to biological materials, particular to endothelial cells, or that interfere with, or prevent the chemotaxis of leukocytes through the endothelial cell monolayer, consequently minimizing undesirable cell/tissue leukocyte binding and thus preventing or minimizing diseases resulting therefrom.
REFERENCES:
patent: 4797277 (1989-01-01), Arfors
Rudinger, Peptide Hormones (Jun. 1976) 1, 5-6.
Kishimoto et al. Cell vol. 48, 681 (Feb. 1987).
Kishimoto et al. Adv. In. Immun. vol. 46 (1989) ATIJO.
Abbas et al. Cell. & Mol. Immun (1991) at 158.
Hogg, N., 1989, Letters, pp. 111-114.
Kaymakcalan Zehra
Liu David Y.
Mundy Kirsten
Cashion Jr. Merrell C.
Celsa B.
Green Grant D.
Halluin Albert P.
McGarrigle, Jr. Philip J.
LandOfFree
Peptide medicaments for the treatment of disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide medicaments for the treatment of disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide medicaments for the treatment of disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-503120